BREAKTHROUGHS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPS

Recombinant human serum albumin (OsrHSA) has emerged as a major innovation in the sphere of biopharmaceuticals, providing promising breakthroughs throughout many clinical and industrial programs. With its structural similarity to Obviously derived human serum albumin, OsrHSA presents a safer, additional reputable choice for therapeutic use, specifi